Natco Pharma logo

Natco Pharma CEO, MD, chairman, board of directors and AGM

NSE: NATCOPHARMBSE: 524816Pharmaceuticals & BiotechnologySmall Cap

Last close ₹791.85up ₹6.70 (0.85%)BSE ₹792.20

Share price at the NSE close on 23 Oct 2026. Previous close ₹785.15.

52-week range of traded prices to 23 Oct 2026
₹773.60Low, 22 Oct 2026₹1,226.80High, 12 May 2026
Market cap
₹15,534 Cr380th largest listed
P/E
13.6
P/B
Shares changed
Dividend yield
0.57%
ROE
13.6%
ROCE
8.6%
Debt to equity
0.08
Volume, NSE
5,69,53550.8% delivered

Natco Pharma board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • Chairperson and managing directorVENKAIAH CHOWDARY NANNAPANENI
  • Chief executiveRAJEEV NANNAPANENI
  • Company Secretary and Compliance OfficerCHEKURI VENKAT RAMESH

9 directors5 independent4 executive

  • VENKAIAH CHOWDARY NANNAPANENI · Chairperson and managing directorExecutive · joined Sep 1981 · reappointed Apr 2026 · 1 listed board · 1 committee seat
  • RAJEEV NANNAPANENI · Chief executiveExecutive · joined Nov 2005 · reappointed Apr 2026 · 1 listed board · 1 committee seat
  • SIVARAMAKRISHNA PRASAD POTLURIExecutive · joined Nov 2014 · reappointed Apr 2026 · 1 listed board
  • LINGARAO DONTHINENIExecutive · joined Feb 2015 · reappointed Apr 2026 · 1 listed board
  • AGNIHOTRA DAKSHINA MURTY CHAVALIIndependent · joined Apr 2024 · reappointed Apr 2024 · 27 months as independent · 2 listed boards · 2 as independent · 4 committee seats, 2 as chair
  • DRONADULA VIJAYA BHASKARIndependent · joined Apr 2024 · reappointed Apr 2024 · 27 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
  • LAKSHMINARAYANA BOLISETTYIndependent · joined Aug 2024 · reappointed Aug 2024 · 22 months as independent · 3 listed boards · 3 as independent · 3 committee seats, 2 as chair
  • SUMA KANTIPUDIIndependent · joined Aug 2024 · reappointed Aug 2024 · 22 months as independent · 1 listed board · 1 as independent
  • NITIN JAINIndependent · joined Aug 2024 · reappointed Aug 2024 · 22 months as independent · 2 listed boards · 2 as independent · 2 committee seats

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

1 director who left
  • PAVAN G BHAT, left 13 Feb 2025: Others

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 29 May 20269 of 9 present5 independent · 65 days in between
    • 24 Mar 20269 of 9 present5 independent · 39 days in between
    • 12 Feb 20269 of 9 present5 independent

  • Audit Committee

    Chair LAKSHMINARAYANA BOLISETTY

    AGNIHOTRA DAKSHINA MURTY CHAVALI, DRONADULA VIJAYA BHASKAR, NITIN JAIN

    • 29 May 20264 of 4 present4 independent · 65 days in between
    • 24 Mar 20264 of 4 present4 independent · 39 days in between
    • 12 Feb 20264 of 4 present4 independent

  • Nomination and remuneration committee

    Chair DRONADULA VIJAYA BHASKAR

    AGNIHOTRA DAKSHINA MURTY CHAVALI, LAKSHMINARAYANA BOLISETTY, SUMA KANTIPUDI

    • 29 May 20264 of 4 present4 independent · 105 days in between
    • 12 Feb 20264 of 4 present4 independent

  • Stakeholders Relationship Committee

    Chair DRONADULA VIJAYA BHASKAR

    VENKAIAH CHOWDARY NANNAPANENI, RAJEEV NANNAPANENI, NITIN JAIN

    • 29 May 20264 of 4 present2 independent

  • Risk Management Committee

    Chair VENKAIAH CHOWDARY NANNAPANENI

    RAJEEV NANNAPANENI, SIVARAMAKRISHNA PRASAD POTLURI, LINGARAO DONTHINENI, LAKSHMINARAYANA BOLISETTY, A LAKSHMINARAYANA, AMIT PAREKH, BHIMRAO DATTU JADHAV, DR SRIRAM RAMPALLI

    No meeting listed in the filing.

  • Corporate Social Responsibility Committee

    Chair VENKAIAH CHOWDARY NANNAPANENI

    RAJEEV NANNAPANENI, DRONADULA VIJAYA BHASKAR, SUMA KANTIPUDI

    • 29 May 20264 of 4 present2 independent · 105 days in between
    • 12 Feb 20264 of 4 present2 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • B S R and CoPeer-review certificate valid to Apr 2029

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Natco Pharma AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Natco Pharma dividend history

Annual general meeting, 30 Sep 2026

4,22,879 shareholders on the register on 25 Sep 2026; present: 6 promoters and 45 others; votes counted by CS Kiran Kumar Bodla / BK & Associates.The company's voting result (opens in a new tab)

  1. Adoption of Audited Annual Financial Statements for the Financial year 2025-26
    Ordinary
    99.78% for0.22% against

    Against: promoters 0.00% · institutions 0.86% · other public 0.80%

    Turnout: all 65.55% · promoters 98.43% · institutions 73.01% · other public 2.42%

  2. To Confirm three Interim Dividends agreegating to Rs.5/- per shares paid on equity shares during the Financial year 2025-26 as final dividend
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.81%

    Turnout: all 65.71% · promoters 98.43% · institutions 73.73% · other public 2.42%

  3. Re-appointment of Sri P.S.R.K. Prasad (DIN: 07011140) as a Director liable to retire by rotation
    Ordinary
    99.43% for0.57% against

    Against: promoters 0.00% · institutions 2.23% · other public 0.89%

    Turnout: all 65.71% · promoters 98.43% · institutions 73.72% · other public 2.42%

  4. Ratification of remuneration of Cost Auditors
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.93%

    Turnout: all 65.71% · promoters 98.43% · institutions 73.72% · other public 2.42%

  5. To approve raising of funds in one or more tranches, by issuance of securities by way of preferential issue, rights issue, private placement (including qualified institutions placement(s)) and/or any combination thereof or any other method as may be permitted under applicable law for an amount not exceeding Rs. 2,000 croresMoreLess
    Special
    98.94% for1.06% against

    Against: promoters 0.00% · institutions 4.21% · other public 0.99%

    Turnout: all 65.71% · promoters 98.43% · institutions 73.72% · other public 2.42%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 24 Mar 2026, 4 resolutions

4,45,237 shareholders on the register on 13 Feb 2026; votes counted by KIRAN KUMAR BODLA / BK & ASSOCIATES.The company's voting result (opens in a new tab)

  1. To reappoint Sri V.C. Nannapaneni (DIN: 00183315) as Chairman & Managing Director of the Company
    SpecialPromoters have an interest in it
    98.74% for1.26% against

    Against: promoters 0.00% · institutions 5.94% · other public 0.45%

    Turnout: all 62.17% · promoters 97.83% · institutions 63.97% · other public 1.95%

  2. To reappoint Sri Rajeev Nannapaneni (DIN: 00183872) as Vice Chairman and Chief Executive Officer of the Company
    SpecialPromoters have an interest in it
    99.28% for0.72% against

    Against: promoters 0.00% · institutions 3.35% · other public 0.60%

    Turnout: all 62.16% · promoters 97.83% · institutions 63.97% · other public 1.95%

  3. To reappoint Sri P.S.R.K Prasad (DIN: 07011140) as Director and Executive Vice President (Corporate Engineering Services) of the Company
    Special
    99.40% for0.60% against

    Against: promoters 0.00% · institutions 2.82% · other public 0.61%

    Turnout: all 62.16% · promoters 97.83% · institutions 63.97% · other public 1.95%

  4. To reappoint Dr. D. Linga Rao (DIN: 07088404) as Director and President (Tech. Affairs) of the Company
    Special
    99.40% for0.60% against

    Against: promoters 0.00% · institutions 2.82% · other public 0.60%

    Turnout: all 62.17% · promoters 97.83% · institutions 63.97% · other public 1.95%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 25 Sep 2025, 8 resolutions

4,35,402 shareholders on the register on 19 Sep 2025; present: 8 promoters and 54 others; votes counted by B KIRAN KUMAR / BK & Associates.The company's voting result (opens in a new tab)

  1. Adoption of audited Annual Financial Statements for the Financial Year 2024-25
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.25%

    Turnout: all 64.53% · promoters 98.84% · institutions 73.33% · other public 2.76%

  2. To confirm three interim dividends aggregating to Rs. 6.00/- per share paid on equity shares during the Financial Year 2024-25 as dividend for the FY 2024-25
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.26%

    Turnout: all 64.68% · promoters 98.84% · institutions 74.13% · other public 2.75%

  3. Re-appointment of Sri Rajeev Nannapaneni (DIN: 00183872) as a Director liable to retire by rotation.
    Ordinary
    99.86% for0.14% against

    Against: promoters 0.00% · institutions 0.58% · other public 0.45%

    Turnout: all 64.68% · promoters 98.84% · institutions 74.13% · other public 2.75%

  4. Appointment of Secretarial Auditors
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.49%

    Turnout: all 64.67% · promoters 98.84% · institutions 74.06% · other public 2.75%

  5. Ratification of remuneration of Cost Auditors
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.51%

    Turnout: all 64.68% · promoters 98.84% · institutions 74.13% · other public 2.75%

  6. Borrowing Powers of the Company under Section 180(1)(c) of the Companies Act, 2013
    Special
    98.72% for1.28% against

    Against: promoters 0.00% · institutions 5.55% · other public 0.47%

    Turnout: all 64.68% · promoters 98.84% · institutions 74.13% · other public 2.75%

  7. Creation of Charge(s) on the movable and immovable properties of the Company, both present and future, in respect of borrowings under Section 180 (1)(a) of the Companies Act, 2013
    Special
    99.89% for0.11% against

    Against: promoters 0.00% · institutions 0.44% · other public 0.70%

    Turnout: all 64.68% · promoters 98.84% · institutions 74.13% · other public 2.75%

  8. To increase the Authorized Share Capital of the Company and consequent alteration to the Capital Clause of the Memorandum of Association
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.58%

    Turnout: all 64.68% · promoters 98.84% · institutions 74.13% · other public 2.75%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 30 Sep 2024, 12 resolutions

Present: 11 promoters and 59 others.The company's voting result (opens in a new tab)

  1. Adoption of audited Annual Financial Statements for the Financial Year 2023-24
    Ordinary
    99.93% for0.07% against

    Against: promoters 0.00% · institutions 0.27% · other public 0.02%

    Turnout: all 66.65% · promoters 97.75% · institutions 70.89% · other public 2.85%

  2. To confirm three interim dividends aggregating to Rs.9.50 per share paid on equity shares during the Financial Year 2023-24 as dividend for the FY 2023-24.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.04%

    Turnout: all 66.95% · promoters 97.75% · institutions 72.11% · other public 2.85%

  3. Re-appointment of Dr. D. Linga Rao (DIN: 07088404) as a Director liable to retire by rotation
    Ordinary
    99.39% for0.61% against

    Against: promoters 0.00% · institutions 2.31% · other public 0.16%

    Turnout: all 66.94% · promoters 97.75% · institutions 72.11% · other public 2.85%

  4. Re-appointment of Dr. Pavan Ganapati Bhat (DIN: 09691260) as a Director liable to retire by rotation
    Ordinary
    99.53% for0.47% against

    Against: promoters 0.00% · institutions 1.75% · other public 0.29%

    Turnout: all 66.94% · promoters 97.75% · institutions 72.11% · other public 2.85%

  5. Appointment of Statutory Auditors
    Ordinary
    99.92% for0.08% against

    Against: promoters 0.00% · institutions 0.29% · other public 0.15%

    Turnout: all 66.94% · promoters 97.75% · institutions 72.11% · other public 2.85%

  6. Ratification of remuneration of Cost Auditors
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.21%

    Turnout: all 66.94% · promoters 97.75% · institutions 72.11% · other public 2.85%

  7. Appointment of Sri Lakshminarayana Bolisetty (DIN 02766709) to the office of Independent Director
    Special
    99.48% for0.52% against

    Against: promoters 0.00% · institutions 1.95% · other public 0.16%

    Turnout: all 66.94% · promoters 97.75% · institutions 72.11% · other public 2.85%

  8. Appointment of Dr. Kantipudi Suma (DIN 02734369) to the office of Independent Director
    Special
    99.48% for0.52% against

    Against: promoters 0.00% · institutions 1.95% · other public 0.16%

    Turnout: all 66.94% · promoters 97.75% · institutions 72.11% · other public 2.85%

  9. Appointment of Sri Nitin Jain (DIN 00136245) to the office of Independent Director
    Special
    99.48% for0.52% against

    Against: promoters 0.00% · institutions 1.95% · other public 0.15%

    Turnout: all 66.94% · promoters 97.75% · institutions 72.11% · other public 2.85%

  10. Revision in the remuneration of Sri P.S.R.K. Prasad (DIN: 07011140) Director and Executive Vice President (Corporate Engineering Services) of the Company
    Ordinary
    99.98% for0.02% against

    Against: promoters 0.00% · institutions 0.04% · other public 0.45%

    Turnout: all 66.95% · promoters 97.75% · institutions 72.11% · other public 2.85%

  11. Revision in the remuneration of Dr. D. Linga Rao (DIN: 07088404) Director and President (Tech. Affairs) of the Company
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.04% · other public 0.31%

    Turnout: all 66.95% · promoters 97.75% · institutions 72.11% · other public 2.85%

  12. Revision in the remuneration of Dr. Pavan Ganapati Bhat (DIN: 09691260) as Director & Executive Vice President (Technical Operations) of the Company
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.04% · other public 0.18%

    Turnout: all 66.94% · promoters 97.75% · institutions 72.11% · other public 2.85%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 26 Mar 2024, 7 resolutions

The company's voting result (opens in a new tab)

  1. To appoint Sri A.D.M. Chavali (DIN: 00374673) as Independent Director of the Company
    Special
    99.74% for0.26% against

    Against: promoters 0.00% · institutions 0.89% · other public 0.45%

    Turnout: all 70.87% · promoters 99.33% · institutions 77.43% · other public 7.68%

  2. To appoint Sri D. Vijaya Bhaskar (DIN:07158951) as Independent Director of the Company
    Special
    99.74% for0.26% against

    Against: promoters 0.00% · institutions 0.89% · other public 0.44%

    Turnout: all 70.86% · promoters 99.33% · institutions 77.43% · other public 7.68%

  3. To appoint Sri V.C. Nannapaneni (DIN: 00183315) as Chairman & Managing Director of the Company
    Special
    90.01% for9.99% against

    Against: promoters 0.00% · institutions 36.16% · other public 0.13%

    Turnout: all 70.86% · promoters 99.33% · institutions 77.43% · other public 7.68%

  4. To appoint Sri Rajeev Nannapaneni (DIN: 00183872) as Vice Chairman and Chief Executive Officer of the Company
    Special
    91.78% for8.22% against

    Against: promoters 0.00% · institutions 29.73% · other public 0.21%

    Turnout: all 70.86% · promoters 99.33% · institutions 77.43% · other public 7.68%

  5. To reappoint Sri P.S.R.K Prasad (DIN: 07011140) as Director and Executive Vice President (Corporate Engineering Services) of the Company
    Special
    94.55% for5.45% against

    Against: promoters 0.00% · institutions 19.73% · other public 0.18%

    Turnout: all 70.86% · promoters 99.33% · institutions 77.43% · other public 7.68%

  6. To reappoint Dr. D. Linga Rao (DIN: 07088404) as Director and President (Tech. Affairs) of the Company
    Special
    94.55% for5.45% against

    Against: promoters 0.00% · institutions 19.73% · other public 0.21%

    Turnout: all 70.86% · promoters 99.33% · institutions 77.43% · other public 7.68%

  7. To reappoint Dr. Pavan Ganapati Bhat (DIN: 09691260) as Director & Executive Vice President (Technical Operations) of the Company
    Special
    94.54% for5.46% against

    Against: promoters 0.00% · institutions 19.73% · other public 0.27%

    Turnout: all 70.86% · promoters 99.33% · institutions 77.43% · other public 7.68%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 29 Sep 2023, 7 resolutions

Present: 5 promoters and 58 others.The company's voting result (opens in a new tab)

  1. Adoption of audited Annual Financial Statements for the Financial Year 2022-23
    OrdinaryPromoters have an interest in it
    99.94% for0.06% against

    Against: promoters 0.00% · institutions 0.20% · other public 0.01%

    Turnout: all 71.92% · promoters 99.32% · institutions 80.35% · other public 4.55%

  2. To confirm three interim dividends aggregating to Rs.5.50 per share paid on equity shares during the Financial Year 2022-23 as dividend for the FY 2022-23.
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 72.08% · promoters 99.32% · institutions 80.93% · other public 4.55%

  3. Reappointment of Sri Rajeev Nannapaneni (DIN: 00183872) as a Director liable to retire by rotation.
    OrdinaryPromoters have an interest in it
    96.07% for3.93% against

    Against: promoters 0.00% · institutions 13.09% · other public 0.12%

    Turnout: all 72.08% · promoters 99.32% · institutions 80.93% · other public 4.55%

  4. Re-appointment of Sri P.S.R.K Prasad (DIN: 07011140) as a Director liable to retire by rotation.
    OrdinaryPromoters have an interest in it
    96.56% for3.44% against

    Against: promoters 0.00% · institutions 11.42% · other public 0.81%

    Turnout: all 72.08% · promoters 99.32% · institutions 80.93% · other public 4.55%

  5. Ratification of remuneration of Cost Auditors
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.16%

    Turnout: all 72.08% · promoters 99.32% · institutions 80.93% · other public 4.55%

  6. Revision in the remuneration of Sri V.C. Nannapaneni (DIN: 00183315) Managing Director
    OrdinaryPromoters have an interest in it
    90.76% for9.24% against

    Against: promoters 0.00% · institutions 30.75% · other public 0.86%

    Turnout: all 72.08% · promoters 99.32% · institutions 80.93% · other public 4.55%

  7. Revision in the remuneration of Sri Rajeev Nannapaneni (DIN: 00183872) Director and Chief Executive Officer
    OrdinaryPromoters have an interest in it
    90.76% for9.24% against

    Against: promoters 0.00% · institutions 30.75% · other public 0.87%

    Turnout: all 72.08% · promoters 99.32% · institutions 80.93% · other public 4.56%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 30 Sep 2022, 5 resolutions

Present: 7 promoters and 79 others.The company's voting result (opens in a new tab)

  1. Adoption of audited Annual Financial Statements for the Financial Year 2021-22
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.13%

    Turnout: all 69.50% · promoters 97.90% · institutions 83.11% · other public 4.39%

  2. To confirm three interim dividends aggregating to Rs.4.50 per share paid on equity shares during the Financial Year 2021-22 as dividend for the FY 2021-22.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.18%

    Turnout: all 69.53% · promoters 97.90% · institutions 83.20% · other public 4.39%

  3. Reappointment of Dr. D. Linga Rao (DIN: 07088404) as a Director liable to retire by rotation
    Ordinary
    96.12% for3.88% against

    Against: promoters 0.00% · institutions 13.07% · other public 0.42%

    Turnout: all 69.53% · promoters 97.90% · institutions 83.20% · other public 4.39%

  4. Ratification of remuneration of Cost Auditors
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.46%

    Turnout: all 69.53% · promoters 97.90% · institutions 83.20% · other public 4.39%

  5. Appointment of Dr. Pavan Ganapati Bhat (DIN: 09691260) as Director & Executive Vice President (Technical Operations) of the Company
    Special
    97.73% for2.27% against

    Against: promoters 0.00% · institutions 7.62% · other public 0.57%

    Turnout: all 69.53% · promoters 97.90% · institutions 83.20% · other public 4.39%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 25 Mar 2022, 4 resolutions

The company's voting result (opens in a new tab)

  1. To appoint Sri V.C. Nannapaneni (DIN: 00183315) as Managing Director of the Company.
    Special
    97.02% for2.98% against

    Against: promoters 0.00% · institutions 10.56% · other public 0.25%

    Turnout: all 70.67% · promoters 99.55% · institutions 66.07% · other public 10.28%

  2. To appoint Sri Rajeev Nannapaneni (DIN: 00183872) as Director and Chief Executive Officer.
    Special
    97.57% for2.43% against

    Against: promoters 0.00% · institutions 8.58% · other public 0.30%

    Turnout: all 70.67% · promoters 99.55% · institutions 66.07% · other public 10.28%

  3. To reappoint Sri P.S.R.K Prasad (DIN: 07011140) as Director and Executive Vice President (Corporate Engineering Services).
    Special
    93.30% for6.70% against

    Against: promoters 0.00% · institutions 23.74% · other public 0.37%

    Turnout: all 70.67% · promoters 99.55% · institutions 66.07% · other public 10.28%

  4. To reappoint Dr.D.Linga Rao (DIN: 07088404) as Director and President (Tech. Affairs).
    Special
    93.30% for6.70% against

    Against: promoters 0.00% · institutions 23.74% · other public 0.29%

    Turnout: all 70.67% · promoters 99.55% · institutions 66.07% · other public 10.28%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it

Mutual fund votes, meeting of 30 Sep 2026, 9 fund houses so far (houses' deadline to file 15 Oct 2026)

  • Adoption of Audited Annual Financial Statements for the Financial year 2025-26
    9 for0 against
  • To Confirm three Interim Dividends agreegating to Rs.5/- per shares paid on equity shares during the Financial year 2025-26 as final dividend
    9 for0 against
  • Re-appointment of Sri P.S.R.K. Prasad (DIN: 07011140) as a Director liable to retire by rotation
    9 for0 against
  • Ratification of remuneration of Cost Auditors
    9 for0 against
  • To approve raising of funds in one or more tranches, by issuance of securities by way of preferential issue, rights issue, private placement (including qualified institutions placement(s)) and/or any combination thereof or any other method as may be permitted under applicable law for an amount not exceeding Rs. 2,000 croresMoreLess
    Against Angel One Mutual Fund, Edelweiss Mutual Fund, Navi Mutual Fund
    • Angel One Mutual FundGovernance concern: Significant dilution and no clarity regarding the reasons behind not opting for Rights Issue.
    • Edelweiss Mutual Fund, Navi Mutual FundCompliant with law. Governance concern: Significant dilution and no clarity regarding the reasons behind not opting for Rights Issue.
    6 for3 against

Mutual fund votes, meeting of 24 Mar 2026, 19 fund houses

  • To reappoint Sri V.C. Nannapaneni (DIN: 00183315) as Chairman & Managing Director of the Company
    Against Angel One Mutual Fund, Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Zerodha Mutual Fund
    • Angel One Mutual FundGovernance Concern: Combined position of Chairman & Managing Director; may lead to concentration of power in the hands of single person.
    • Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Zerodha Mutual FundCompliant with law. No concern on the merits of appointee. Governance Concern: Combined position of Chairman & Managing Director; may lead to concentration of power in the hands of single person.
    12 for7 against
  • To reappoint Sri Rajeev Nannapaneni (DIN: 00183872) as Vice Chairman and Chief Executive Officer of the Company
    Against Angel One Mutual Fund, Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Zerodha Mutual Fund
    • Angel One Mutual FundGovernance Concern: Remuneration skewed in favour of proposed appointee.
    • Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Zerodha Mutual FundCompliant with law. No concern on the merits of appointee. Governance Concern: Remuneration skewed in favour of proposed appointee.
    12 for7 against
  • To reappoint Sri P.S.R.K Prasad (DIN: 07011140) as Director and Executive Vice President (Corporate Engineering Services) of the Company
    19 for0 against
  • To reappoint Dr. D. Linga Rao (DIN: 07088404) as Director and President (Tech. Affairs) of the Company
    19 for0 against
6 earlier meetings

Mutual fund votes, meeting of 25 Sep 2025, 19 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Adoption of audited Annual Financial Statements for the Financial Year 2024-25
    19 for0 against
  • To confirm three interim dividends aggregating to Rs. 6.00/- per share paid on equity shares during the Financial Year 2024-25 as dividend for the FY 2024-25
    19 for0 against
  • Re-appointment of Sri Rajeev Nannapaneni (DIN: 00183872) as a Director liable to retire by rotation.
    Against Angel One Mutual Fund, Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Zerodha Mutual Fund
    • Angel One Mutual FundGovernance concern: Skewed remuneration in favour of Promoter Executive Directors.
    • Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Zerodha Mutual FundCompliant with law. No issue on merit of appointee. Governance concern: Skewed remuneration in favour of Promoter EDs.
    12 for7 against
  • Appointment of Secretarial Auditors
    19 for0 against
  • Ratification of remuneration of Cost Auditors
    19 for0 against
  • Creation of Charge(s) on the movable and immovable properties of the Company, both present and future, in respect of borrowings under Section 180 (1)(a) of the Companies Act, 2013
    Against Angel One Mutual Fund, Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Kotak Mahindra Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Zerodha Mutual Fund
    • Angel One Mutual FundGovernance Concern: The Entire Existing Borrowing Limit is unutilized and no specific reasons/justification provided for the utilization of the proposed limit.
    • Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Zerodha Mutual FundInterlinked with resolution #6.
    • Kotak Mahindra Mutual FundApprove creation of charge on assets to secure borrowings upto the borrowing limit. Since the resolution is linked to resolution #6, we do not support the resolution.
    11 for8 against
  • To increase the Authorized Share Capital of the Company and consequent alteration to the Capital Clause of the Memorandum of Association
    19 for0 against
3 proposals not matched to one resolution
  • 6) Approve increase in borrowing limits to Rs. 10.0 bn over and above paid-up capital, free reserves and securities premium.
    1 for0 against
  • Approve increase in borrowing limits to Rs. 10.0 bn over and above paid-up capital, free reserves and securities premium
    Against Jio BlackRock Mutual Fund, Sundaram Mutual Fund
    • Jio BlackRock Mutual Fund, Sundaram Mutual FundThe company proposes to increase its borrowing limit considering its growth plans and funds it may require for capital expenditure, ongoing expansion plans, and modernization of its plant facilities - to tap the emerging business opportunities or inorganic opportunities to accelerate the growth. The company, currently is in the process of a significant acquisition, offering to buy a 35.75% stake in the South African pharmaceutical company, Adcock Ingram Holdings. The deal is valued at ~Rs. 20.0 bn. As on 31 March 2025, as per regulations, the automatic borrowing limit was Rs. 73.0 bn, debt was Rs 2.7 bn and debt to equity was at 0.04x. The company’s debt programme is rated ICRA AA/Stable/ICRA A1+, which denotes high degree of safety regarding timely servicing of long-term financial obligations. Considering the headroom available under the existing limits and sufficient cash reserves aggregating Rs. 35.0 bn as per con-call transcripts, the need for an increase in limit is unclear. Also, we do not favour rolling limits linked to net worth and recommend that companies seek approval for a fixed quantum. We do not support this resolution.
    1 for2 against
  • To borrow at its discretion, either from the Company’s Bankers or any other Indian or Foreign Bank(s), Financial Institution(s) and / or any other Lending Institutions or persons from time to time such that the sum(s) of money(s) and the sum(s) to be borrowed for the purpose of Company’s business together with the money(s) already borrowed by the Company (apart from temporary loans obtained or working capital arrangements obtained or to be obtained from the Company’s bankers in the ordinary course of business) as they may think fit and necessary in the best interest of the Company, up to an amount of Rs. 1,000 Crores over and above the aggregate of paid-up capital and free reserves and securities premium of the Company at any time.MoreLess
    Against Angel One Mutual Fund, Axis Mutual Fund, Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Kotak Mahindra Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Nippon India Mutual Fund, Zerodha Mutual Fund
    • Angel One Mutual Fund, Nippon India Mutual FundGovernance Concern: The Entire Existing Borrowing Limit is unutilized and no specific reasons/justification provided for the utilization of the proposed limit.
    • Axis Mutual FundThe company proposes to increase its borrowing limit considering its growth plans and funds it may require for capital expenditure, ongoing expansion plans, and modernization of its plant facilities - to tap the emerging business opportunities or inorganic opportunities to accelerate the growth. The company, currently is in the process of a significant acquisition, offering to buy a 35.75% stake in the South African pharmaceutical company, Adcock Ingram Holdings. The deal is valued at ~Rs. 20.0 bn. As on 31 March 2025, as per regulations, the automatic borrowing limit was Rs. 73.0 bn, debt was Rs 2.7 bn and debt to equity was at 0.04x. The company’s debt programme is rated ICRA AA/Stable/ICRA A1+, which denotes high degree of safety regarding timely servicing of long-term financial obligations. Considering the headroom available under the existing limits and sufficient cash reserves aggregating Rs. 35.0 bn as per con-call transcripts, the need for an increase in limit is unclear. Also, we do not favour rolling limits linked to net worth and recommend that companies seek approval for a fixed quantum. We do not support this resolution.
    • Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Zerodha Mutual FundCompliant with the law. Governance Concern: The Entire Existing Borrowing Limit is unutilized and no specific reasons/justification provided for the utilization of the proposed limit.
    • Kotak Mahindra Mutual FundThe company proposes to increase its borrowing limit considering its growth plans and funds it may require for capital expenditure, ongoing expansion plans, and modernization of its plant facilities - to tap the emerging business opportunities or inorganic opportunities to accelerate the growth. The company, currently is in the process of a significant acquisition, offering to buy a 35.75% stake in the South African pharmaceutical company, Adcock Ingram Holdings. The deal is valued at ~Rs. 20.0 bn. As on 31 March 2025, as per regulations, the automatic borrowing limit was Rs. 73.0 bn, debt was Rs 2.7 bn and debt to equity was at 0.04x. The company s debt programme is rated ICRA AA/Stable/ICRA A1+, which denotes high degree of safety regarding timely servicing of longterm financial obligations. Considering the headroom available under the existing limits and sufficient cash reserves aggregating Rs. 35.0 bn as per con-call transcripts, the need for an increase in limit is unclear. We do not support this resolution.
    5 for10 against

Mutual fund votes, meeting of 30 Sep 2024, 14 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Adoption of audited Annual Financial Statements for the Financial Year 2023-24
    13 for0 against
  • To confirm three interim dividends aggregating to Rs.9.50 per share paid on equity shares during the Financial Year 2023-24 as dividend for the FY 2023-24.
    14 for0 against
  • Re-appointment of Dr. D. Linga Rao (DIN: 07088404) as a Director liable to retire by rotation
    14 for0 against
  • Re-appointment of Dr. Pavan Ganapati Bhat (DIN: 09691260) as a Director liable to retire by rotation
    14 for0 against
  • Appointment of Statutory Auditors
    Against Bandhan Mutual Fund, Groww Mutual Fund
    • Bandhan Mutual Fund, Groww Mutual FundNon-Compliant with Regulation 36(5) of SEBI LODR: Proposed audit fee and credentials of auditors not disclosed.
    12 for2 against
  • Ratification of remuneration of Cost Auditors
    14 for0 against
  • Appointment of Sri Lakshminarayana Bolisetty (DIN 02766709) to the office of Independent Director
    14 for0 against
  • Appointment of Dr. Kantipudi Suma (DIN 02734369) to the office of Independent Director
    14 for0 against
  • Appointment of Sri Nitin Jain (DIN 00136245) to the office of Independent Director
    14 for0 against
  • Revision in the remuneration of Sri P.S.R.K. Prasad (DIN: 07011140) Director and Executive Vice President (Corporate Engineering Services) of the Company
    14 for0 against
  • Revision in the remuneration of Dr. D. Linga Rao (DIN: 07088404) Director and President (Tech. Affairs) of the Company
    14 for0 against
  • Revision in the remuneration of Dr. Pavan Ganapati Bhat (DIN: 09691260) as Director & Executive Vice President (Technical Operations) of the Company
    14 for0 against
2 proposals not matched to one resolution
  • . To receive, consider and adopt the audited consolidated financial statements of the Company for the financial year ended March 31, 2024, together with the Report of the Auditors’ thereon.
    1 for0 against
  • To receive, consider and adopt the Audited Financial Statements, both on Standalone and Consolidated basis of the Company for the Financial Year ended March 31, 2024, together with the reports of Board of Directors, and the Auditors and other reports thereon.MoreLess
    1 for0 against

Mutual fund votes, meeting of 26 Mar 2024, 10 fund houses

  • To appoint Sri A.D.M. Chavali (DIN: 00374673) as Independent Director of the Company
    10 for0 against
  • To appoint Sri D. Vijaya Bhaskar (DIN:07158951) as Independent Director of the Company
    10 for0 against
  • To appoint Sri V.C. Nannapaneni (DIN: 00183315) as Chairman & Managing Director of the Company
    Against Bandhan Mutual Fund, Groww Mutual Fund, ICICI Prudential Mutual Fund, Motilal Oswal Mutual Fund
    • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance concern: Holding Chairman & Managing Director position and no absolute cap on commission and total remuneration.
    • ICICI Prudential Mutual FundThe AMC has voted against the resolution as the AMC believes that the company has not disclosed or put an absolute cap on the proposed Commission, rather it has capped relatively with Net Profit of the Company. The remuneration should be capped adequately both in terms i.e. relative as well as absolute specially in the case of promoters of the company. The Company has placed a relative cap of upto 1% of Net Profit which means that the Commission is dependent on the Net profit and if there is an exceptional increase in Net profit in financial year then the Commission will increase proportionately.
    6 for4 against
  • To appoint Sri Rajeev Nannapaneni (DIN: 00183872) as Vice Chairman and Chief Executive Officer of the Company
    Against Bandhan Mutual Fund, Groww Mutual Fund, ICICI Prudential Mutual Fund, Motilal Oswal Mutual Fund
    • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance concern: No absolute cap on commission and total remuneration.
    • ICICI Prudential Mutual FundThe AMC has voted against the resolution as the AMC believes that the company has not disclosed or put an absolute cap on the Commission proposed, rather it has capped relatively with Net Profit of the Company. The remuneration should be capped adequately in both terms i.e. relative as well as absolute specially in the case of promoters of the company. The Company has placed a relative cap of upto 1% of Net Profit which means that the Commission is dependent on the Net profit and if there is an exceptional increase in Net profit in financial year then the Commission will increase proportionately.
    6 for4 against
  • To reappoint Sri P.S.R.K Prasad (DIN: 07011140) as Director and Executive Vice President (Corporate Engineering Services) of the Company
    10 for0 against
  • To reappoint Dr. D. Linga Rao (DIN: 07088404) as Director and President (Tech. Affairs) of the Company
    10 for0 against
  • To reappoint Dr. Pavan Ganapati Bhat (DIN: 09691260) as Director & Executive Vice President (Technical Operations) of the Company
    10 for0 against

Mutual fund votes, meeting of 29 Sep 2023, 13 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Adoption of audited Annual Financial Statements for the Financial Year 2022-23
    12 for0 against
  • To confirm three interim dividends aggregating to Rs.5.50 per share paid on equity shares during the Financial Year 2022-23 as dividend for the FY 2022-23.
    12 for0 against
  • Reappointment of Sri Rajeev Nannapaneni (DIN: 00183872) as a Director liable to retire by rotation.
    12 for0 against
  • Re-appointment of Sri P.S.R.K Prasad (DIN: 07011140) as a Director liable to retire by rotation.
    12 for0 against
  • Ratification of remuneration of Cost Auditors
    12 for0 against
  • Revision in the remuneration of Sri V.C. Nannapaneni (DIN: 00183315) Managing Director
    Against JM Financial Mutual Fund
    • JM Financial Mutual FundCompliant with law. Governance concern: No absolute cap on commission and total remuneration
    2 for1 against
  • Revision in the remuneration of Sri Rajeev Nannapaneni (DIN: 00183872) Director and Chief Executive Officer
    Against JM Financial Mutual Fund
    • JM Financial Mutual FundCompliant with law. Governance concern: No absolute cap on commission and total remuneration
    2 for1 against
3 proposals not matched to one resolution
  • 1. Adoption of audited Annual Financial Statements for the Financial Year 2022-2023 2. To confirm three interim dividends aggregating to Rs. 5.50 per share paid on equity shares 3. Re-appointment of Sri Rajeev Nannapaneni (DIN: 00183872) as a Director liable to retire by rotation 4. Re-appointment of Sri P.S.R.K Prasad (DIN: 07011140) as a Director liable to retire by rotation 5. Ratification of remuneration of Cost Auditors 6. Revision in the remuneration of Sri V.C. Nannapaneni (DIN: 00183315) Managing Director. 7. Revision in the remuneration of Sri Rajeev Nannapaneni (DIN: 00183872) Director and CEOMoreLess
    1 for0 against
  • To revise one of the terms in the appointment of Sri Rajeev Nannapaneni (DIN: 00183872) as Director and Chief Executive Officer i.e., by increasing the Managerial Commission from 0.5% to 1% for the financial year 2023-24.MoreLess
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundCompliant with law. Governance concern: No absolute cap on commission and total remuneration
    8 for1 against
  • To revise one of the terms in the appointment of Sri V.C. Nannapaneni (DIN: 00183315) Managing Director i.e., by increasing the Managerial Commission from 0.5% to 1% for the financial year 2023-24.
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundCompliant with law. Governance concern: No absolute cap on commission and total remuneration
    8 for1 against

Mutual fund votes, meeting of 30 Sep 2022, 10 fund houses

  • Adoption of audited Annual Financial Statements for the Financial Year 2021-22
    10 for0 against
  • To confirm three interim dividends aggregating to Rs.4.50 per share paid on equity shares during the Financial Year 2021-22 as dividend for the FY 2021-22.
    10 for0 against
  • Reappointment of Dr. D. Linga Rao (DIN: 07088404) as a Director liable to retire by rotation
    10 for0 against
  • Ratification of remuneration of Cost Auditors
    10 for0 against
  • Appointment of Dr. Pavan Ganapati Bhat (DIN: 09691260) as Director & Executive Vice President (Technical Operations) of the Company
    10 for0 against

Mutual fund votes, meeting of 25 Mar 2022, 12 fund houses

  • To appoint Sri V.C. Nannapaneni (DIN: 00183315) as Managing Director of the Company.
    12 for0 against
  • To appoint Sri Rajeev Nannapaneni (DIN: 00183872) as Director and Chief Executive Officer.
    12 for0 against
  • To reappoint Sri P.S.R.K Prasad (DIN: 07011140) as Director and Executive Vice President (Corporate Engineering Services).
    12 for0 against
  • To reappoint Dr.D.Linga Rao (DIN: 07088404) as Director and President (Tech. Affairs).
    12 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Fines and stakes in unlisted companies

Reported in the filing for the quarter to Jun 2026.

  • Unlisted stake boughtCellogen Therapeutics Private LimitedSince 10 Apr 2026

    0.24% bought in the quarter; holding 5.62%, from 5.38%

  • Fine or penaltyOffice of the Assistant Commissioner of central tax, 2nd Floor, Aditi Crystal, Nellore 524 003Since 22 Jun 2026

    GST ADT 02 issued under rule 101(5) of CGST rules to communicate audit observations for the audit period of FY 2020-21 to 2023-24 . Tax payable 811670/- and penaltyamount 1,21,753/-

    Wrong availament of input tax credit, short payment of regular tax and RCM
  • Fine or penaltyOFFICE OF THE DEPUTY COMMISSIONER,, STATE TAX CIRCLE-13,, INDORESince 11 Apr 2026

    DRC 01A intimation of tax ascertained being payable U/2 74(5)/122/125/50 and under rule 142(1A). Tax 135/- and penalty 135/-

    Irregular distribution of ISD credit
  • Fine or penaltyFSSAISince 29 Apr 2026

    Improvement notice issued under Section 32 of Food Safety and Standards, Act 2006 and imposed a penalty of Rs. 41,064/-

    Non submission of Annual return for 2024-25

In the company's own words, from its latest governance filing.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

None open at any quarter's end.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
Yes
The filing has a part on fines and penalties
Yes
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.